A biotechnology company is looking to offload half of its leased space in the San Francisco Peninsula as the biotech real estate market struggles with increasing vacancies.
A biotechnology company is looking to offload half of its leased space in the San Francisco Peninsula as the biotech real estate market struggles with increasing vacancies.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
750 Gateway Blvd, South San Francisco, CA
Real Estate